Inflammatory cytokines such as IL1β and IL6, chemokines, and matrix metalloproteinases as well as a variety of inflammatory transcription factors are upregulated and activated in patients affected by RCC, both systemically and inside the tumor site (16–23). The gene discussed is IL1B; the disease is neoplasm.